Last update:

Oncology news

Preoperative chemo and immunotherapy combo shrinks head, neck cancer tumors

Combining chemotherapy with immunotherapy before surgery for head and neck cancer is associated with significantly greater reductions in tumor size than immunotherapy alone, according to a study published online Aug. 13 in ...

How loss of tumor suppressor drives ER+ breast cancer to metastasize to the bone

A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells' preference to metastasize to bone.

Exploring precision medicine for pancreatic cancer

Imagine if, before starting cancer care, doctors could rapidly identify the most effective chemotherapy, immunotherapy or combination to personalize treatment for a loved one's hard-to-treat pancreatic cancer and improve ...

A unified framework to explain one of cancer's major drivers

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, Ph.D., associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham ...

How 'undead' cells trigger cancer-promoting inflammation

Stopping tumor growth is only half the battle. Rather than killing tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells ...

How highly aggressive colon cancer evades the immune system

Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system.

Math and medicine join forces to solve a cancer mystery

Immunotherapy has transformed outcomes for many cancer patients. Unlike conventional treatments, these therapies do not attack tumors directly. Instead, they enable the body's immune system to identify and kill cancer cells ...

Newly found 'immune organ' inside skull directs brain defense

Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders ...

Blood cancer marker could help identify patients at high risk

Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at greatest risk of poor outcomes, enabling more personalized and effective treatments. Multiple myeloma ...

Blood vessels guide immune cells to metastases

It has long been suspected that endothelial cells, the specialized cells lining the inner walls of blood vessels, play a key role in determining how the body's immune system responds to tumors. Researchers at the German Cancer ...

No evidence mobile phones cause brain cancer—new study

Electromagnetic waves are everywhere. They're the reason you can hear music when you turn on the radio, use Wi-Fi, find your way using satellite navigation, and make calls on a mobile phone. They are a form of electromagnetic ...

Microbiota dysbiosis triggers intestinal cancer stemness

Scientists at National Taiwan University College of Medicine have discovered that cancer formation is not simply caused by gene mutations. Colorectal cancers primarily originate from epithelial cells that form adenocarcinomas ...